Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -20.24% is 25% above its 5-year average of -27.07%, near the high end of its 5-year range (-50.36%–-12.55%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.58% below its 12-month average of -17.51%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -20.24%.
RETURN ON INVESTED CAPITAL (ROIC)
-20.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-17.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-20.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-27.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.58%
CURRENT VS 3Y AVG
+1.19%
CURRENT VS 5Y AVG
+25.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+43.21%
vs the sector median at left
RxSight, Inc.
Market Cap
$191.67M
Return on Invested Capital (ROIC)
-20.24%
TTM Avg
-17.51%
3Y Avg
-20.49%
5Y Avg
-27.07%
Market Cap
$192.56M
Return on Invested Capital (ROIC)
-105.17%
TTM Avg
-54.92%
3Y Avg
-54.02%
5Y Avg
-50.29%
Market Cap
$189.50M
Return on Invested Capital (ROIC)
-74.02%
TTM Avg
-48.91%
3Y Avg
-62.69%
5Y Avg
-47.07%
Market Cap
$184.04M
Return on Invested Capital (ROIC)
-51.01%
TTM Avg
-69.12%
3Y Avg
-59.60%
5Y Avg
-89.29%
Market Cap
$183.17M
Return on Invested Capital (ROIC)
-9.57%
TTM Avg
-477.38%
3Y Avg
-295.61%
5Y Avg
-295.61%
Market Cap
$200.77M
Return on Invested Capital (ROIC)
-41.61%
TTM Avg
-54.73%
3Y Avg
-70.67%
5Y Avg
-64.43%
Market Cap
$181.62M
Return on Invested Capital (ROIC)
-46.59%
TTM Avg
-39.23%
3Y Avg
-33.74%
5Y Avg
-53.74%
Market Cap
$201.78M
Return on Invested Capital (ROIC)
-71.04%
TTM Avg
-53.65%
3Y Avg
-40.34%
5Y Avg
-35.55%
Market Cap
$181.30M
Return on Invested Capital (ROIC)
-3.21%
TTM Avg
-7.29%
3Y Avg
-11.96%
5Y Avg
-13.56%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RxSight, Inc. (RXST) | $191.67M | -20.24% | -17.51% | -20.49% | -27.07% |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $192.56M | -105.17% | -54.92% | -54.02% | -50.29% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.50M | -74.02% | -48.91% | -62.69% | -47.07% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $184.04M | -51.01% | -69.12% | -59.60% | -89.29% |
| Canton Strategic Holdings Inc (CNTN)vs › | $183.17M | -9.57% | -477.38% | -295.61% | -295.61% |
| Surrozen, Inc. (SRZN)vs › | $200.77M | -41.61% | -54.73% | -70.67% | -64.43% |
| Compass Therapeutics, Inc. (CMPX)vs › | $181.62M | -46.59% | -39.23% | -33.74% | -53.74% |
| Alector, Inc. (ALEC)vs › | $201.78M | -71.04% | -53.65% | -40.34% | -35.55% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $181.30M | -3.21% | -7.29% | -11.96% | -13.56% |
| Exagen Inc. (XGN)vs › | $202.49M | -33.88% | -37.38% | -46.28% | -37.99% |
ROIC
-20.2%
ROE
-17.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -20.24% |
| 2026-03-31 | -19.90% |
| 2025-12-31 | -16.88% |
| 2025-09-30 | -15.82% |
| 2025-06-30 | -14.74% |
| 2025-03-31 | -12.70% |
| 2024-12-31 | -12.55% |
| 2024-09-30 | -13.58% |
| 2024-06-30 | -14.82% |
| 2024-03-31 | -28.91% |
| 2023-12-31 | -30.64% |
| 2023-09-30 | -33.29% |
| 2023-06-30 | -32.27% |
| 2023-03-31 | -31.89% |
| 2022-12-31 | -47.63% |
| 2022-09-30 | -45.21% |
| 2022-06-30 | -39.13% |
| 2022-03-31 | -34.99% |
| 2021-12-31 | -29.06% |
| 2021-09-30 | -23.86% |
| 2021-06-30 | -50.36% |
| 2021-03-31 | -41.47% |
| 2020-12-31 | -39.67% |
